Visceral Fat and Metabolic Aging: What the Research Shows

CK
By Dr. Charles Kamen MD
Board-Certified Neurologist  |  Albert Einstein College of Medicine

Visceral Fat and Metabolic Aging: What the Research Shows

TL;DR — Visceral adipose tissue (VAT) — the fat stored around internal organs — behaves differently from subcutaneous fat. A 2019 international consensus statement published in Nature Reviews Endocrinology highlights VAT as a distinct and clinically meaningful driver of cardiometabolic risk, independent of overall body weight. The strongest evidence for reducing visceral fat points to combined aerobic and resistance training, adequate sleep, and metabolic-health-focused nutrition.


Not all body fat is equal

Body fat is distributed across multiple depots, and they are not equivalent. The two broadest categories are:

  • Subcutaneous adipose tissue (SAT) — fat beneath the skin, the kind pinched in a skinfold test.
  • Visceral adipose tissue (VAT) — fat stored around internal organs in the abdominal cavity.

VAT is more metabolically active than SAT. It secretes inflammatory cytokines, alters hepatic lipid metabolism, and is more closely linked to insulin resistance, cardiovascular disease, and type 2 diabetes than overall adiposity [1].

Two people with identical body weights can have very different amounts of visceral fat — and, as a result, very different cardiometabolic risk profiles.

→ For the broader framework, see our pillar: The Science of Longevity.

What the 2019 consensus statement concluded

In 2019, an international group of obesity and cardiometabolic researchers published a consensus statement in Nature Reviews Endocrinology summarizing the evidence on visceral fat, ectopic fat, and cardiometabolic risk [1]. Key points:

  • VAT is a distinct risk factor, not simply a marker of total adiposity.
  • Individuals with normal BMI but elevated VAT ("normal weight obesity") carry cardiometabolic risk that is underestimated by BMI alone.
  • Lifestyle interventions — particularly those combining aerobic exercise, resistance training, and dietary changes — consistently reduce VAT, often more than they reduce subcutaneous fat or total body weight.
  • Waist circumference, though imperfect, is a more informative screening metric than BMI for cardiometabolic risk.

How visceral fat connects to the hallmarks of aging

Visceral fat accumulation is mechanistically connected to several hallmarks of aging described in the 2023 update to the López-Otín framework [2]:

  • Deregulated nutrient sensing — VAT drives insulin resistance and alters nutrient-signaling pathways.
  • Chronic inflammation — VAT secretes pro-inflammatory cytokines that contribute to systemic low-grade inflammation.
  • Mitochondrial dysfunction — VAT accumulation is associated with impaired mitochondrial function in multiple tissues.

Reducing visceral fat is, in effect, one of the most practical ways to address several of these hallmarks simultaneously.

What the evidence supports for reducing VAT

The lifestyle variables most consistently associated with reductions in visceral fat overlap heavily with the broader longevity playbook.

1. Combined aerobic and resistance training

Meta-analyses of exercise intervention trials show that combined aerobic and resistance training reduces visceral fat more consistently than either alone. Aerobic training drives much of the direct fat loss; resistance training preserves lean mass and improves insulin sensitivity.

→ Read more: Zone 2 Cardio and Mitochondrial Health → Read more: Resistance Training and Healthspan After 50

2. Adequate sleep

Sleep restriction is associated with altered glucose tolerance, increased hunger hormones, and — over time — changes in body composition that favor visceral fat accumulation. Protecting sleep is not a secondary variable in metabolic health; it's a primary one.

→ Read more: Sleep Architecture and Biological Aging

3. Nutritional quality and protein adequacy

Nutrition interventions that reduce visceral fat tend to share common features: adequate protein intake to preserve lean mass during any weight loss, emphasis on whole foods, and controlled total energy intake. The specific "diet" matters less than long-term sustainability and adherence.

→ Read more: Protein Intake and Sarcopenia Prevention After 40

How to assess visceral fat

Several methods exist, with different trade-offs:

  • Imaging (CT or MRI) — the gold standard; expensive and involves radiation exposure in the case of CT.
  • DXA scans — widely available, moderate accuracy for visceral fat estimation.
  • BIA (bioelectrical impedance) — consumer scales that estimate visceral fat; useful for tracking trends but with meaningful error.
  • Waist circumference — a simple tape measure, and surprisingly informative. Published thresholds by sex and ethnicity can help identify elevated risk.

For most people starting out, waist circumference trends over time provide a reasonable, low-cost signal.

What the research does not support

  • Spot reduction. There is no reliable evidence that targeted abdominal exercises selectively reduce visceral fat.
  • Miracle supplements. No supplement has been shown in rigorous trials to specifically and durably reduce visceral fat.
  • Extreme restriction. Very low-calorie diets can reduce fat rapidly but are difficult to sustain and can compromise lean mass without adequate protein.

Sustainable reductions in visceral fat come from consistent training, sleep, and nutrition over months to years — not weeks.


Frequently asked questions

What is the difference between visceral fat and subcutaneous fat? Subcutaneous fat is stored beneath the skin; visceral fat is stored around internal organs in the abdominal cavity. Visceral fat is more metabolically active and more strongly associated with cardiometabolic risk.

Can you be "skinny fat"? Yes. Individuals with normal BMI can have elevated visceral fat and a cardiometabolic risk profile similar to that of people with higher BMIs. BMI alone is an imperfect screening tool.

Is waist circumference useful? Yes. Published thresholds (for example, ≥102 cm in men and ≥88 cm in women for many populations) help identify elevated cardiometabolic risk and are inexpensive to measure.

Does targeted ab training reduce belly fat? No. Targeted exercises can strengthen abdominal muscles but do not selectively reduce visceral fat. Overall exercise and nutrition patterns drive visceral fat reductions.


About the author

Charles Kamen, MD earned his medical degree from Albert Einstein College of Medicine and completed his internal medicine internship at Yale-New Haven Hospital, followed by a neurology residency at Loma Linda University. He is board-certified by the American Board of Psychiatry and Neurology.

Citations

  1. Neeland IJ, Ross R, Després JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715-725. PMID: 31301983
  2. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278. PMID: 36599349

This article is for educational purposes and does not constitute medical advice. Consult a qualified clinician before making significant changes to your diet or exercise regimen.